Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ALISHA JOY STINEMETZ

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1083144539
CMS profile
10834864
Location
LYONS, KS

General Payments · PY2021–2024

$697.50

  • Reported across 38 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$280.44

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $280.44 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $66.54 3
Lundbeck LLC $45.76 3
ITI, Inc. $44.44 2
Teva Pharmaceuticals USA, Inc. $38.46 2
Amgen Inc. $24.69 1
Otsuka America Pharmaceutical, Inc. $21.52 1
Novo Nordisk AS $20.18 1
Alkermes, Inc. $18.85 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $50.09 3
PY2022 $151.25 9
PY2023 $215.72 12
PY2024 $280.44 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $17.68 01/26/2024 Food and Beverage Undisputed 01/23/2026 1108257095 CMS
ABBVIE INC. $27.32 06/05/2024 Food and Beverage Undisputed 01/23/2026 1108257097 CMS
ABBVIE INC. $21.54 09/12/2024 Food and Beverage Undisputed 01/23/2026 1108257099 CMS
Alkermes, Inc. $18.85 04/10/2024 Food and Beverage Undisputed 01/23/2026 1120603465 CMS
Amgen Inc. $24.69 06/24/2024 Food and Beverage Undisputed 01/23/2026 1116152999 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.72 01/24/2024 Food and Beverage Undisputed 01/23/2026 1143610360 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.72 03/13/2024 Food and Beverage Undisputed 01/23/2026 1143610362 CMS
Lundbeck LLC $17.04 02/01/2024 Food and Beverage Undisputed 01/23/2026 1146094590 CMS
Lundbeck LLC $14.23 04/24/2024 Food and Beverage Undisputed 01/23/2026 1146094592 CMS
Lundbeck LLC $14.49 08/29/2024 Food and Beverage Undisputed 01/23/2026 1146094594 CMS
Novo Nordisk Inc $20.18 09/26/2024 Food and Beverage Undisputed 01/23/2026 1100636601 CMS
Otsuka America Pharmaceutical, Inc. $21.52 04/22/2024 Food and Beverage Undisputed 01/23/2026 1119193520 CMS
Teva Pharmaceuticals USA, Inc. $16.86 08/28/2024 Food and Beverage Undisputed 01/23/2026 1151591669 CMS
Teva Pharmaceuticals USA, Inc. $21.60 10/31/2024 Food and Beverage Undisputed 01/23/2026 1151591757 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.